TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
PCVX

Vaxcyte Inc

Healthcare · Biotechnology

58.10$ -3.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PCVX
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
91.7% 94.2% 93.9% 99.0% 79.0% 93.7% 77.8% 50.9% 53.4%
91.2% 93.3% 89.8% 98.3% 21.3% 83.0% 28.2% 11.0% 5.7%
91.2% 93.3% 89.8% 98.3% 75.8% 92.6% 76.7% 49.8% 51.2%
0.3% 0.1% 0.4% 0.1% 0.3% 0.6% 1.5%
-0.3% -0.1% -0.4% -0.1% -0.4%
7.5% 4.8% 5.2% 0.8% 11.1% 3.1%
21.9% 181.5% 261.9% 12.0% 12.4% 5.2% 11.9% 5.9% 11.8%
10.8% 9.5% 16.8% 11.9% 8.9% 4.0% 10.3% 4.0% 6.8%
0.7% 0.4% 0.2% 1.6% 0.6% 0.5% 0.2% 0.2%
4.6% 4.0% 5.1% 7.6% 2.1% 1.0% 1.0% 1.4% 2.3%
9.5% 5.2% 0.7%
78.1% -81.5% -161.9% 88.0% 87.6% 94.8% 88.1% 94.1% 88.2%
-74.7% -83.4% -166.4% -50.5% -92.1% -51.9% -65.7% -39.5% -70.7%
9.0% 36.2% 74.4% 7.5% 16.0% 6.4% 6.9% 3.5% 4.5%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?